Tag Archives: Lorenzo Biasio

Clovis Oncology (CLVS) Receives a Buy from Credit Suisse

In a report issued on May 13, Lorenzo Biasio from Credit Suisse maintained a Buy rating on Clovis Oncology (CLVS – Research Report), with a price target of $29. The company’s shares closed yesterday at $18.77. According to TipRanks.com, Biasio

Credit Suisse Thinks Mylan Inc’s Stock is Going to Recover

In a report released today, Lorenzo Biasio from Credit Suisse maintained a Buy rating on Mylan Inc (MYL – Research Report), with a price target of $37. The company’s shares opened today at $28.11, close to its 52-week low of